# INOVIO PHARMACEUTICALS INC (INOXXXX)

> Institutional ownership reported to the SEC as of Q1 2024, from Form 13F filings. Source: https://holderbook.com/stocks/INOXXXX/

- Reporting holders: 3
- Reported value: $143.6K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Prime Capital Investment Advisors, LLC](https://holderbook.com/funds/1731446-prime-capital-investment-advisors-llc/) | $141.2K | 10,172 | 0.0% | 5 |
| [IFP Advisors, Inc](https://holderbook.com/funds/1641866-ifp-advisors-inc/) | $2.4K | 175 | 0.0% | 17 |
| [Sachetta, LLC](https://holderbook.com/funds/2010574-sachetta-llc/) | $2 | 3 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2024 | 3 | $143.6K |
| Q4 2023 | 108 | $26.1M |
| Q3 2023 | 126 | $21.8M |
| Q2 2023 | 135 | $32.3M |
| Q1 2023 | 174 | $100.4M |
| Q4 2022 | 183 | $201.2M |
| Q3 2022 | 162 | $203.5M |
| Q2 2022 | 159 | $199.9M |
| Q1 2022 | 181 | $337.1M |
| Q4 2021 | 195 | $473.2M |
| Q3 2021 | 205 | $600.8M |
| Q2 2021 | 210 | $736.6M |